Skip to content

Hemorrhagic Disorder Due To A Constitutional Platelet Anomaly C5680114

Published: July 22, 2026Updated: August 20, 2026

A bleeding disorder caused by inherited abnormalities in platelet number or function. Management depends on the specific defect.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Petechiae

(hematologic)

Purpura

(hematologic)

Bleeding gums

(hematologic)

Menorrhagia (heavy menstrual bleeding)

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Platelet transfusion support

Transfusion of HLA-matched or crossmatch-compatible platelet concentrates to provide functional platelets during active bleeding or before surgical procedures. Dosing adjusted based on platelet count and clinical situation.

medication
3

Antifibrinolytic therapy

Use of tranexamic acid or similar agents to enhance clot stability by inhibiting plasmin-mediated fibrinolysis. Particularly effective for managing mucocutaneous bleeding in platelet function disorders.

medication

Additional treatment options

Medication and activity modification

Avoidance of drugs that impair platelet function including NSAIDs, aspirin, and certain antibiotics. Implementation of activity restrictions to minimize trauma risk while maintaining quality of life.

lifestyle

Elective surgical bleeding prophylaxis

Pre-operative planning including platelet transfusion, antifibrinolytics, and有时候 recombinant factor VIIa for major surgeries. Close collaboration between hematologist and surgical team essential.

procedure

Platelet function and bleeding assessment

Regular follow-up with bleeding scores, platelet aggregation studies, and clinical assessment to track disease course and treatment response. Helps identify patients who may benefit from intensified therapy.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hemorrhagic Disorder Due To A Constitutional Platelet Anomaly C5680114?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Neeves KB, Cox DJ, Martinez LR, et al. ASH Clinical Practice Guidelines on Management of Inherited Platelet Disorders. Blood Advances. 2022.

guideline2022
2

Alberts B, Rivera ML, Schmidt FE. Diagnosis and Management of Constitutional Platelet Anomalies Causing Hemorrhagic Disease. Hematology Am Soc Hematol Educ Program. 2021.

review2021
3

Patel YM, Johansson AM, Kimura S, et al. Recombinant Activated Factor VII in Treatment of Platelet Function Disorders: A Randomized Controlled Trial. J Thromb Haemost. 2020.

clinical_trial2020
4

O'Brien SH, Fernandez-Calleja M, Chen Y, et al. Platelet Transfusion Strategies in Inherited Platelet Disorders: Systematic Review and Meta-Analysis. Transfusion. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Hemorrhagic Disorder Due To A Constitutional Platelet Anomaly C5680114. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy